https://kffhealthnews.org/news/article/novo-nordisk-ozempic-denmark-obesity-diabetes-drugs-cost/?utm_campaign=KHN%20-%20Weekly%20Edition&utm_medium=email&_hsenc=p2ANqtz--X_9WGxyu_gGIqNKJvHF5u6ehKP4Ew1IocOnbja_AI_dTmeZGlRrcBswFAEpPT4sRLiztGs6at9ZhNVzNcE6lRSKNZpw&_hsmi=319436113&utm_content=319436113&utm_source=hs_email
How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices
By Arthur Allen
As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark — Ozempic maker Novo Nordisk’s home — has limited coverage of the drug after cost overruns “emptied all the money boxes in the entire public health system.”
No hay comentarios:
Publicar un comentario